According to a new report by Polaris Market Research, the global gene expression analysis market was valued at USD 4.22 billion in 2025 and is projected to reach USD 7.97 billion by 2034, expanding at a CAGR of 7.35% from 2026 to 2034. Growth is underpinned by rising demand for precision-medicine diagnostics, expanding chronic-disease burden, and continued advancement in next-generation sequencing and AI-assisted bioinformatics.

What Is Driving Gene Expression Analysis Market Growth?

Demand is climbing as growth in the biotechnology and biopharmaceutical industries converges with rising cancer-research investment. Pharmaceutical companies and academic institutions are prioritizing next-generation sequencing and AI-assisted bioinformatics, pushing gene expression analysis adoption across drug discovery, clinical diagnostics, and personalized-medicine programs. Polaris analysts note that rising investment in genomics and life-science research positions the drug discovery & development segment for sustained double-digit growth through 2034, with reagents & consumables emerging as the largest revenue contributor and pharmaceutical & biotechnology companies posting the fastest incremental gains among end users.

Key Trends Shaping the Gene Expression Analysis Industry

AI-Assisted Bioinformatics Accelerating Discovery

Machine learning is being applied to large genomic datasets to surface biologically significant biomarkers and disease patterns faster, improving both the speed and reliability of gene-expression data analysis while supporting the shift toward personalized medicine and integrated clinical outcomes.

Next-Generation Sequencing Reshaping Research Workflows

A major shift toward next-generation sequencing (NGS) technologies is transforming genomics by enabling simultaneous analysis of millions of DNA sequences in a single run, making large-scale studies faster and more cost-effective than traditional PCR or microarray methods and reinforcing this technology advancement across research and clinical settings.

Cloud-Based Genomics Platforms Expanding Access

Cloud computing is easing storage, management, and analysis of large gene-expression datasets, allowing distributed research groups to access shared data and computing capacity without on-site infrastructure — a shift that is broadening the competitive landscape beyond traditional instrument-led vendors.

Market Segmentation: Breaking Down the Gene Expression Analysis Market

Polaris segments the gene expression analysis market by product & service, application, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

Read More @ https://www.polarismarketresearch.com/industry-analysis/gene-expression-analysis-market

By Product & Service

Reagents & consumables led the market with a 51.7% share in 2025, reflecting steady, repeat demand for primers, probes, enzymes, and nucleotides used across PCR, microarray, and next-generation sequencing workflows, while instruments and services round out the remaining revenue.

By Application

Drug discovery & development is projected to expand at a 12.6% CAGR, the fastest among application segments, driven by rising chronic-disease incidence such as cancer, diabetes, and cardiovascular disorders that is creating sustained demand for novel, more targeted therapeutics.

By End User

Pharmaceutical & biotechnology companies are projected to grow at a 12.1% CAGR, the fastest among end-user segments, as rising need for biomarker identification pushes drugmakers to expand in-house and outsourced gene-expression analysis capacity alongside academic and research institutes.

Regional Outlook: Where Is Gene Expression Analysis Growing Fastest?

North America dominated the market with a 42.3% share in 2025, supported by advanced technological infrastructure, substantial R&D investment, and a flourishing biotechnology sector with strong academia-industry partnerships. Asia Pacific is projected to grow at an 11.8% CAGR, the fastest of any region, driven by rising interest in genomics research and personalized medicine, particularly in China and India, where expanding research infrastructure is drawing a growing share of global collaborations and investment.

Competitive Landscape: Leading Gene Expression Analysis Companies

Key players are focusing on AI partnerships, product launches, and platform expansions to strengthen market position across the drug discovery and pharmaceutical & biotechnology segments outlined above. Recent moves include QIAGEN's partnership with NVIDIA to advance AI-driven drug discovery, BGI Genomics' launch of its AI-powered SIROmics high-throughput testing solution, and Takara Bio's expansion of its Trekker single-cell spatial mapping kits to support FFPE tissue samples.

Key players profiled include Agilent Technologies, Inc., BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Illumina, Inc., LGC Biosearch Technologies, Oxford Nanopore Technologies plc, PacBio, Promega Corporation, QIAGEN, Standard BioTools, Thermo Fisher Scientific Inc..

Why It Matters for Buyers Evaluating Precision-Diagnostics Market Entry

For stakeholders researching the gene expression analysis opportunity, this report benchmarks market share, segment-level pricing, and forecast data — by product & service, application, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking AI-assisted bioinformatics as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

top-medical-laser-systems-companies-redefining-healthcare-and-aesthetics

top-10-dark-chocolate-manufacturers-in-global-market-2024

saffron-market

cell-culture-matrices-market

uqd-coupling-market

global-age-related-macular-degeneration-amd-market

freeze-drying-equipment-market

ophthalmic-drug-market

non-human-identity-nhi-access-management-market